Back to Search
CHRISTOS EMMANOUILIDES, MD
MD
Hematology & Oncology Physician
NPI: 1780600619Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A50601(CA)
Research & Publications (20)
Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.
PMID 17979571·Cancer Biother Radiopharm·2007
1-meta
Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
PMID 16690521·Leuk Lymphoma·2006
8-other
Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma.
PMID 15245607·Clin Lymphoma·2004
3-trial
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer.
PMID 15655642·Tech Coloproctol·2004
3-trial
Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma.
PMID 14561985·Bone Marrow Transplant·2003
8-other
Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL.
PMID 14579238·Hematol Oncol·2003
8-other
Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.
PMID 12435284·Clin Lymphoma·2002
3-trial
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
PMID 12537665·Cancer Biother Radiopharm·2002
8-other
A randomized phase II study of amifostine used as stem cell protectant in non-hodgkin lymphoma patients receiving cisplatin-based salvage chemotherapy prior to stem cell transplant.
PMID 11798515·J Hematother Stem Cell Res·2001
3-trial
Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.
PMID 11707827·Clin Lymphoma·2000
8-other
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
PMID 17537235·BMC Cancer·2007
3-trial
Radioimmunotherapy for non-hodgkin lymphoma : historical perspective and current status.
PMID 18040144·J Clin Exp Hematop·2007
6-review
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
PMID 19015393·Blood·2009
3-trial
Establishment of an animal model for Waldenström's macroglobulinemia.
PMID 19302921·Exp Hematol·2009
7-preclinical
The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat.
PMID 18845186·Neurotoxicology·2008
7-preclinical
Adrenalectomy for solitary adrenal metastasis from colorectal cancer: A case report.
PMID 18638404·Cases J·2008
8-other
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.
PMID 18853418·Cancer·2008
3-trial
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
PMID 18021468·Clin Lymphoma Myeloma·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLAZA, #365
LOS ANGELES, CA 90095 - Phone
- (310) 825-0631
Quick Facts
- NPI
- 1780600619
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile